Literature DB >> 21676498

Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.

Afia Akram1, James Schmeidler, Pavel Katsel, Patrick R Hof, Vahram Haroutunian.   

Abstract

Inheritance of the ε4 allele of apolipoprotein E (ApoE) is the only confirmed and consistently replicated risk factor for late onset Alzheimer's disease (AD). ApoE is also a key ligand for low-density lipoprotein (LDL) receptor-related protein (LRP), a major neuronal low-density lipoprotein receptor. Despite the considerable converging evidence that implicates ApoE and LRP in the pathogenesis of AD, the precise mechanism by which ApoE and LRP modulate the risk for AD remains elusive. Moreover, studies investigating expression of ApoE and LRP in AD brain have reported variable and contradictory results. To overcome these inconsistencies, we studied the mRNA expression of ApoE and LRP in the postmortem brain of persons who died at different stages of dementia and AD-associated neuropathology relative to controls by quantitative polymerase chain reaction (qPCR) and Western blotting analyses. Clinical dementia rating scores were used as a measure of dementia severity, whereas, Braak neuropathological staging and neuritic plaque density were used as indexes of the neuropathological progression of AD. ApoE and LRP mRNA expression was significantly elevated in the postmortem inferior temporal gyrus (area 20) and the hippocampus from individuals with dementia compared with those with intact cognition. In addition to their strong association with the progression of cognitive dysfunction, LRP and ApoE mRNA levels were also positively correlated with increasing neuropathological hallmarks of AD. Additionally, Western blot analysis of ApoE protein expression in the hippocampus showed that the differential expression observed at the transcriptional level is also reflected at the protein level. Given the critical role played by LRP and ApoE in amyloid beta (Aβ) and cholesterol trafficking, increased expression of LRP and ApoE may not only disrupt cholesterol homeostasis but may also contribute to some of the neurobiological features of AD, including plaque deposition.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676498      PMCID: PMC3234309          DOI: 10.1016/j.neurobiolaging.2011.04.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  116 in total

Review 1.  Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.

Authors:  M C Irizarry; G W Rebeck; B Cheung; K Bales; S M Paul; D Holzman; B T Hyman
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Abeta-generating enzymes: recent advances in beta- and gamma-secretase research.

Authors:  R Vassar; M Citron
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

Review 3.  LRP: a multifunctional scavenger and signaling receptor.

Authors:  J Herz; D K Strickland
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain.

Authors:  S Grehan; E Tse; J M Taylor
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

5.  Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro.

Authors:  Z Qiu; D K Strickland; B T Hyman; G W Rebeck
Journal:  J Neuropathol Exp Neurol       Date:  2001-05       Impact factor: 3.685

6.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

7.  N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.

Authors:  S Dracheva; S A Marras; S L Elhakem; F R Kramer; K L Davis; V Haroutunian
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

8.  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

Authors:  D E Kang; C U Pietrzik; L Baum; N Chevallier; D E Merriam; M Z Kounnas; S L Wagner; J C Troncoso; C H Kawas; R Katzman; E H Koo
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

Authors:  M Shibata; S Yamada; S R Kumar; M Calero; J Bading; B Frangione; D M Holtzman; C A Miller; D K Strickland; J Ghiso; B V Zlokovic
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

10.  Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65.

Authors:  A Kinoshita; C M Whelan; C J Smith; I Mikhailenko; G W Rebeck; D K Strickland; B T Hyman
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more
  15 in total

Review 1.  Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.

Authors:  Mitsuru Shinohara; Masaya Tachibana; Takahisa Kanekiyo; Guojun Bu
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

Review 2.  ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.

Authors:  Yonghe Li; Jesse R Macyczko; Chia-Chen Liu; Guojun Bu
Journal:  Neurobiol Aging       Date:  2022-03-22       Impact factor: 5.133

3.  The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.

Authors:  Colton Linnertz; Lauren Anderson; William Gottschalk; Donna Crenshaw; Michael W Lutz; Jawara Allen; Sunita Saith; Mirta Mihovilovic; James R Burke; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2014-01-15       Impact factor: 21.566

Review 4.  Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.

Authors:  Juan M Zolezzi; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

5.  Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.

Authors:  Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

6.  Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.

Authors:  Corbin Bachmeier; Ben Shackleton; Joseph Ojo; Daniel Paris; Michael Mullan; Fiona Crawford
Journal:  Neuromolecular Med       Date:  2014-12       Impact factor: 3.843

7.  The Role of Upregulated APOE in Alzheimer's Disease Etiology.

Authors:  William K Gottschalk; Mirta Mihovilovic; Allen D Roses; Ornit Chiba-Falek
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-02-09

8.  Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.

Authors:  Qi Zhang; Cheng Ma; Marla Gearing; Peng George Wang; Lih-Shen Chin; Lian Li
Journal:  Acta Neuropathol Commun       Date:  2018-03-01       Impact factor: 7.801

9.  The APOE gene cluster responds to air pollution factors in mice with coordinated expression of genes that differs by age in humans.

Authors:  Amin Haghani; Max Thorwald; Todd E Morgan; Caleb E Finch
Journal:  Alzheimers Dement       Date:  2020-11-20       Impact factor: 21.566

10.  Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.

Authors:  Corey T Watson; Panos Roussos; Paras Garg; Daniel J Ho; Nidha Azam; Pavel L Katsel; Vahram Haroutunian; Andrew J Sharp
Journal:  Genome Med       Date:  2016-01-19       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.